Tecentriq SC 125 mg

TECENTRIQ SC 125 MG is a subcutaneous solution containing atezolizumab, used for certain cancer treatments. This medication is designed to support immune system function.

TECENTRIQ SC 125 MG is primarily used in the treatment of various types of cancer. Atezolizumab, the active ingredient, works by helping the immune system recognize and attack cancer cells. This medication is often prescribed for patients with specific types of cancer, such as lung cancer or urothelial carcinoma. The solution is administered subcutaneously, making it a convenient option for some patients.

Common effects of TECENTRIQ SC 125 MG may include fatigue, nausea, and injection site reactions. Some patients may experience changes in appetite or weight. It's important to discuss any persistent or severe side effects with a healthcare provider.

TECENTRIQ SC 125 MG should be handled with care and stored as directed. It is essential to follow the administration instructions provided by a healthcare professional. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment.

TECENTRIQ SC 125 MG may interact with other medications, including those that affect the immune system. It's important to inform your healthcare provider about all medications you are taking. Alcohol and certain foods may also interact with this medication, so it's best to consult with a healthcare professional for personalized advice.